Literature DB >> 2878887

Role of plasmid-encoded adherence factors in adhesion of enteropathogenic Escherichia coli to HEp-2 cells.

S Knutton, M M Baldini, J B Kaper, A S McNeish.   

Abstract

Plasmid-encoded adherence factors have been shown to be important for the full expression of enteropathogenic Escherichia coli (EPEC) pathogenicity and for EPEC adhesion to cultured HEp-2 cells. EPEC strain E2348 (O127) shows localized HEp-2 cell adhesion and possesses a 60-megadalton plasmid, pMAR2. When E2348 is cured of pMAR2 it loses the ability to adhere to HEp-2 cells, while nonadherent E. coli K-12 strains P678-54 and HB101 acquire HEp-2 adhesiveness after they gain the plasmid. By electron microscopy, E2348 was seen to adhere to HEp-2 cells in a manner that closely resembled EPEC adhesion to intestinal mucosa; bacteria were intimately attached to projections of the apical HEp-2 cell membrane and caused localized destruction of microvilli. The plasmid-containing K-12 strains, on the other hand, did not show intimate attachment and there was no modification of cell surface architecture. It is concluded that plasmid pMAR2 codes for an adhesin, possibly fimbrial in nature, that promotes HEp-2 adhesion but that other chromosomally encoded factors are required for EPEC to achieve the characteristic mode of intimate cell attachment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2878887      PMCID: PMC260282          DOI: 10.1128/iai.55.1.78-85.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Attachment and penetration of Escherichia coli into intestinal epithelium of the ileum in newborn pigs.

Authors:  T E Staley; E W Jones; L D Corley
Journal:  Am J Pathol       Date:  1969-09       Impact factor: 4.307

Review 2.  Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains.

Authors:  W Gaastra; F K de Graaf
Journal:  Microbiol Rev       Date:  1982-06

3.  Plasmid-mediated adhesion in enteropathogenic Escherichia coli.

Authors:  M M Baldini; J B Kaper; M M Levine; D C Candy; H W Moon
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983       Impact factor: 2.839

4.  Pathogenesis of escherichia coli gastroenteritis in man--another mechanism.

Authors:  M H Ulshen; J L Rollo
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

Review 5.  The bacterial glycocalyx in nature and disease.

Authors:  J W Costerton; R T Irvin; K J Cheng
Journal:  Annu Rev Microbiol       Date:  1981       Impact factor: 15.500

6.  Mucosal adherence of human enteropathogenic Escherichia coli.

Authors:  A S McNeish; P Turner; J Fleming; N Evans
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

7.  A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants.

Authors:  R Rothbaum; A J McAdams; R Giannella; J C Partin
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

8.  Pathogenic effect of enterotoxigenic Escherichia coli and Escherichia coli causing infantile diarrhoea.

Authors:  Y E Polotsky; E M Dragunskaya; V G Seliverstova; T A Avdeeva; M G Chakhutinskaya; I Kétyi; A Vertényl; B Ralovich; L Emödy; I Málovics; N V Safonova; E S Snigirevskaya; E I Karyagina
Journal:  Acta Microbiol Acad Sci Hung       Date:  1977

9.  Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.

Authors:  H W Moon; S C Whipp; R A Argenzio; M M Levine; R A Giannella
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Hemagglutination and colonization factors in enterotoxigenic and enteropathogenic Escherichia coli that cause diarrhea.

Authors:  M M Levine; M B Rennels; V Daya; T P Hughes
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

View more
  67 in total

Review 1.  Enteropathogenic Escherichia coli.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

2.  Modulation of enteropathogenic Escherichia coli virulence by quorum sensing.

Authors:  Marcelo P Sircili; Matthew Walters; Luis R Trabulsi; Vanessa Sperandio
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  BfpB, an outer membrane lipoprotein required for the biogenesis of bundle-forming pili in enteropathogenic Escherichia coli.

Authors:  S W Ramer; D Bieber; G K Schoolnik
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

4.  The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid.

Authors:  A E Jerse; J B Kaper
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

5.  Bundle-forming pili and EspA are involved in biofilm formation by enteropathogenic Escherichia coli.

Authors:  Cristiano G Moreira; Kelli Palmer; Marvin Whiteley; Marcelo P Sircili; Luiz R Trabulsi; Antonio F P Castro; Vanessa Sperandio
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

6.  QseA directly activates transcription of LEE1 in enterohemorrhagic Escherichia coli.

Authors:  Faith C Sharp; Vanessa Sperandio
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

Review 7.  Inter-kingdom signalling: communication between bacteria and their hosts.

Authors:  David T Hughes; Vanessa Sperandio
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

8.  Interaction with pig ileal explants of Escherichia coli O45 isolates from swine with postweaning diarrhea.

Authors:  C Zhu; J Harel; M Jacques; J M Fairbrother
Journal:  Can J Vet Res       Date:  1995-04       Impact factor: 1.310

9.  Effect of enteropathogenic Escherichia coli on adherent properties of Chinese hamster ovary cells.

Authors:  R P Vanmaele; M C Finlayson; G D Armstrong
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coli.

Authors:  J A Girón; F Qadri; T Azim; K J Jarvis; J B Kaper; M J Albert
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.